Journal article · 2022 · Open access
"Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions"
Journal of Pharmaceutical Negative Results · Published 31 December 2022 · DOI 10.47750/pnr.2022.13.s10.462
In brief
“"Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions"” is a 2022 journal article by Sruthi Nair, published in Journal of Pharmaceutical Negative Results. OpenAlex counts 1 citations as of 15 November 2026. It is open access: the full text is free to read at Journal of Pharmaceutical Negative Results.
- Citations
- 1
- Most cited in
- 2023 (1)
- Field-weighted impact
- 0.08
- Authors
- 1
Abstract
Artificial intelligence (AI) is revolutionizing the pharmaceutical industry by expediting drug development, improving patient outcomes, and reducing the cost of drug discovery. AI is used to predict the safety, efficacy, and side effects of a drug, to optimize the dosages, and to identify new targets for drug development. AI algorithms are trained on large data sets, such as patient records, clinical trials, and genetic information, to identify patterns and correlations that can guide drug discovery and development. AI is also used to design and test drugs in silico, using computer simulations and virtual models, which can save time and resources compared to traditional laboratory experiments. Furthermore, AI-powered devices, such as wearable sensors and smart pills, can monitor patients' health status, adherence to medication, and disease progression, providing real-time data for personalized treatment. AI is also transforming clinical trials, by improving patient recruitment, stratification, and retention, and by reducing the risk of placebo effects and biases. The integration of AI with other technologies, such as blockchain and nanotechnology, can also enhance the security, traceability, and delivery of drugs. Overall, AI is transforming the pharmaceutical industry by accelerating innovation, improving efficiency, and advancing patient-centered care.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nair, S. (2022). "Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions". Journal of Pharmaceutical Negative Results. https://doi.org/10.47750/pnr.2022.13.s10.462
MLA 9
Nair, Sruthi. “"Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions".” Journal of Pharmaceutical Negative Results, 2022. https://doi.org/10.47750/pnr.2022.13.s10.462.
Chicago
Nair, Sruthi. 2022. “"Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions".” Journal of Pharmaceutical Negative Results. https://doi.org/10.47750/pnr.2022.13.s10.462.
Harvard
Nair, S. (2022) ‘"Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions"’, Journal of Pharmaceutical Negative Results. doi:10.47750/pnr.2022.13.s10.462.
IEEE
S. Nair, “"Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions",” Journal of Pharmaceutical Negative Results, 2022, doi: 10.47750/pnr.2022.13.s10.462.
BibTeX
@article{nair2022revolutionizing,
title = {{"Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions"}},
author = {Nair, Sruthi},
journal = {Journal of Pharmaceutical Negative Results},
year = {2022},
doi = {10.47750/pnr.2022.13.s10.462},
url = {https://doi.org/10.47750/pnr.2022.13.s10.462}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence
- drug discovery
- pharmaceutical industry
- computer-aided drug design
- clinical trials
- patient recruitment
- wearable sensors
- smart pills
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Nair, S. (2022). "Revolutionizing Medicine: How AI Is Powering The Future Of Pharmaceutical Inventions". Journal of Pharmaceutical Negative Results. https://doi.org/10.47750/pnr.2022.13.s10.462
How many times has this paper been cited?
1 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal of Pharmaceutical Negative Results.
Who wrote this paper?
Sruthi Nair.
What is the DOI of this paper?
10.47750/pnr.2022.13.s10.462. The permanent link is https://doi.org/10.47750/pnr.2022.13.s10.462.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.